Related Experiment Video
Updated: Jul 22, 2026

In Vitro Characterization of the Electrophysiological Properties of Colonic Afferent Fibers in Rats
Published on: September 27, 2017
[Sacral neuromodulation in fecal continence disorders].
Giuseppe Paolo Ferulano1, Salvatore La Manna, Saverio Dilillo
1Area di Chirurgia Funzionale e Riabilitativa dell'Apparato Digerente, Dipartimento di Patologia Sistematica, Università Federico II, Napoli. ferulano@unina.it
Sacral neuromodulation offers a promising treatment for fecal incontinence, potentially correcting the defect and improving quality of life. Early results show significant success in recovery or improvement for patients.
Area of Science:
- Neuroscience
- Gastroenterology
- Urology
Background:
- Conventional therapies for fecal incontinence often yield limited long-term success, especially when not caused by structural damage.
- Fecal incontinence significantly impacts patients' quality of life and incurs social costs.
- Sacral neuromodulation, successful in treating bladder incontinence, presents a potential alternative for fecal incontinence.
Purpose of the Study:
- To detail the application of sacral neuromodulation using Interstim (Medtronic) devices for fecal incontinence.
- To discuss the indications, protocol, and early outcomes of this therapeutic approach.
- To review current literature and present initial findings from our experience.
Main Methods:
- Application of magnetic stimulation to sacral roots to modulate autonomic nervous system reflex activity.
- Utilized Interstim (Medtronic) devices following a protocol established with the Italian Group of Sacral Neuromodulation (GINS).
- Evaluation included instrumental and clinical assessments, alongside subjective quality of life assessments.
Main Results:
- Early and intermediate results indicate success in achieving complete recovery or significant improvement in fecal continence.
- Both clinical evidence and subjective patient evaluations of quality of life demonstrate positive outcomes.
- The technique is considered 'work in progress' with ongoing research into its precise mechanisms of action on pelvic floor and colorectal motility.
Conclusions:
- Sacral neuromodulation is a viable and promising therapeutic option for fecal incontinence.
- The technique shows potential for long-term correction of fecal incontinence, improving patient quality of life.
- Further research is needed to fully elucidate the mechanisms and long-term efficacy, with ongoing studies exploring its use in refractory constipation.
Related Concept Videos
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a program...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome III: Medical and Nursing Management

